IPO reforms set to boost M&A activity

Australia’s dealmaking environment may be entering a more dynamic phase. Over the last 12 months, Australia has introduced targeted reforms to shorten IPO timetables and reduce execution risk for eligible ASX listings:

• ASX’s update to Guidance Note 1 (effective 30 May 2025) clarifies admissions practice and encourages earlier, more structured engagement.
• ASX is also considering lowering the minimum free‑float threshold for new listings to make it easier for companies to IPO.
• In parallel, ASIC’s 2‑year fast‑track IPO pilot (from 10 June 2025) adds a confidential pre‑lodgement review of ‘pathfinder’ offer documents and a class ‘no‑action’ position allowing retail applications during the exposure period.

Collectively, these measures are designed to increase IPO throughput, compress the ‘on risk’ window and improve certainty. Critically, they should elevate the effectiveness of dual‑track IPO and trade sale processes by increasing competitive tension.

Faster IPO timelines strengthen negotiating power

ASX’s major refresh of Guidance Note 1, has clarified and streamlined key listing requirements. For IPO candidates, the most impactful change is the enhanced fast‑track listing process, which can cut ASX’s review period from 6 weeks to as little as 2 for qualifying companies.

Meanwhile, ASIC is piloting confidential, pre‑lodgement reviews of draft prospectuses, bringing Australian IPOs closer to global practice. This significantly compresses the window between transaction launch and trading, reducing the ‘at‑risk’ period for issuers. Extended timelines increase the likelihood of market volatility, prompting investors to demand steeper discounts and extending the duration of underwriting agreements, heightening termination risk. By compressing this timeline, the fast-track process supports more confident institutional bookbuilds, mitigates the need for significant IPO pricing discounts and enhances underwriting certainty.

From an M&A perspective, a faster, more predictable IPO timetable gives sellers an alternative path that potential acquirers must take seriously. A dual‑track process is only effective when both paths are executable. The shortened window enhances deal certainty and allows vendors to credibly pivot to IPO if sale negotiations falter or valuations diverge.

Greater predictability increases competitive tension

ASIC’s shift to confidential pathfinder prospectus reviews, combined with a stable 7‑day exposure period that is now rarely extended, reduces regulatory uncertainty.

ASX’s updated guidance also provides clearer early‑engagement expectations for foreign companies and early‑stage tech and biotech issuers, giving these businesses faster clarity on listing suitability.

Predictability allows vendors to run a dual‑track process confidently in parallel. The more certain the IPO path, the more leverage sellers have when negotiating terms with potential acquirers.

Improved transparency helps earlier‑stage dual‑track strategies

ASX’s updated guidance for early‑stage technology, biotech and medtech companies formalises existing practices and provides clearer benchmarks for satisfying the assets and operations tests.

Companies that previously viewed IPO readiness as uncertain now have clearer pathways, making them stronger candidates for a dual‑track exit, particularly when strategic acquirers are circling.

Escrow clarity improves post‑listing liquidity outlook

Multiple updates to Guidance Note 15A from 2024 to 2025 clarify escrow arrangements for seed investors, early shareholders and performance securities. These changes reduce ambiguity around post‑listing liquidity.

Greater certainty regarding escrow improves valuation assumptions underpinning both IPO and M&A pathways, supporting cleaner comparisons in a dual‑track process.

Broader M&A benefits of an active IPO market

Beyond dual-track dynamics, a more efficient IPO market supports M&A activity more broadly:

• Faster access to equity capital for acquisitions, enabling newly listed companies to pursue bolt‑ons and consolidation strategies earlier.
• Reduced execution risk for transactions contingent on listings or equity raises.
• Greater competitiveness of ASX‑listed bidders, particularly against offshore or private rivals – key in contested situations.
• Broader pool of credible acquirers and targets, supporting industry consolidation.
• Positive signalling to global capital, reinforcing Australia’s reputation as an execution‑friendly market.

The bottom line

ASX and ASIC reforms are enhancing the Australian IPO market, and in doing so, are likely to stimulate M&A activity. By delivering faster timelines, greater transparency and more certainty, the IPO pathway is becoming a true competitive alternative to a trade sale, creating stronger negotiating positions for sellers and setting the stage for a more active and competitive M&A market through 2026 and beyond.

This article was published as part of the Australian M&A: A review of 2025 and outlook for 2026 publication which you can read here.

If you found this insight article useful and you would like to subscribe to Gadens’ updates, click here.

Authored by:

Jol Rogers, Partner
Michael Kenny, Partner